$NVO has not been able to hold support on the 0.5 Fib for Wave A after a number of a negative announcements came through, however the biggest concern seems to be the market share being lost to their biggest rival $LLY and their popular Wegovy Ozempic drug.
As always, when a Fib support level is not held then the next support level comes into play, in this case it is the 0.618 Fib at $66.
I still do not consider that Wave B has come in yet so I would still expect this next once support is found for Wave A.
David Köster
2025-03-28 18:49:45 +0000 UTCGhulam Murtaza
2025-03-28 14:45:31 +0000 UTCJohn Keys
2025-03-28 14:28:36 +0000 UTCCrewz
2025-03-28 14:23:16 +0000 UTC